NCT07285954 (iWalk) is a NA clinical trial of iWalk Program in Neurodegenerative Disease, sponsored by University of Illinois at Urbana-Champaign.

Who is sponsoring NCT07285954?

NCT07285954 is sponsored by University of Illinois at Urbana-Champaign.

What drugs are being tested in NCT07285954?

Interventions in NCT07285954: iWalk Program.

What condition does NCT07285954 study?

NCT07285954 studies Neurodegenerative Disease, EEG, Mindfulness, Adults.

Is NCT07285954 still recruiting?

NCT07285954 is currently recruiting now. Last updated 16 December 2025.

Last reviewed 2025-12-16 · How we verify

NCT07285954: iWalk

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mindfulness Walking Intervention to Enhance Resilience (iWalk)

Recruiting now NA Last updated 16 December 2025

What this trial tests

NA trial testing iWalk Program in Neurodegenerative Disease in 90 participants. Currently enrolling.

Timeline

1 June 2025

Primary endpoint
31 December 2029

31 December 2029

Quick facts

Lead sponsor	University of Illinois at Urbana-Champaign
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	90
Start date	1 June 2025
Primary completion	31 December 2029
Estimated completion	31 December 2029
Sites	1 location across United States

Drugs / interventions tested

iWalk Program

Conditions studied

Neurodegenerative Disease — all drugs for Neurodegenerative Disease →
EEG — all drugs for EEG →
Mindfulness — all drugs for Mindfulness →
Adults — all drugs for Adults →

Sponsor

University of Illinois at Urbana-Champaign

Who can join

Adults 18 to 110, any sex, with Neurodegenerative Disease or EEG. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized controlled trial of the walking meditation intervention (iWalk) program, a multi-component intervention integrating walking meditation, education, and group sessions designed to enhance resilience in individuals with multiple sclerosis (MS). The objectives are to evaluate: 1. Recruitment capability and retention rates, 2. Acceptability and adherence to the intervention, 3. Feasibility of assessment procedures, and 4. Preliminary effects on psychological, physiological, and behavioral outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Neurodegenerative Disease

Currently open trials in the same condition.

NCT07361887 — Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles. · NA · recruiting
NCT07306598 — [18F]NIDF PET Imaging in Tau-related Diseases · recruiting
NCT06821230 — Dyadic Mindfulness for People With Parkinson's Disease and Their Caregivers · NA · recruiting
NCT06755164 — Effects of Combined Aerobic and Cognitive Training in a Simultaneous or Sequential Paradigm on Cognition and Brain Funct · NA · active not recruiting
NCT00271622 — The Neurodevelopmental and Behavioral Phenotyping Screening Protocol · recruiting

Other University of Illinois at Urbana-Champaign trials

Trials by the same sponsor.

NCT07477067 — Exercise and Protein Efficiency in T2D · NA · recruiting
NCT07367854 — Diet Synergy in Muscle Protein Synthesis · NA · not yet recruiting
NCT07323862 — Assessment of a Method to Improve Cochlear Implant Users' Speech Perception in Noisy Environments While Maintaining Thei · NA · not yet recruiting
NCT07020741 — Stable Isotopes- Adults With Obesity · NA · recruiting
NCT07167680 — Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07285954 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Illinois at Urbana-Champaign
Last refreshed: 16 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07285954.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing